Early Tracheostomy in Ventilated Stroke Patients (SETPOINT)

• Intensive Care Unit Length of Stay (ICU-LOS) [ Time Frame: open ] [ Designated as safety issue: No ]
  The primary endpoint is assessed as days from admission to until discharge from the intensive care unit.
  
  

• Time of ICU-dependence [ Time Frame: open ] [ Designated as safety issue: No ]
  This secondary endpoint is assessed as days from admission to a pre-defined status that would allow discharge from ICU (absence of active infection, vasopressors, pulmonary and cardial instability etc.)
  
  
• Functional Outcome [ Time Frame: admission, discharge, at 6 months ] [ Designated as safety issue: Yes ]
  This secondary endpoint is assessed as the modified Rankin Scale (mRS) at the above named timepoints.
  
  
• Mortality [ Time Frame: during stay, after 6 months ] [ Designated as safety issue: Yes ]
  This secondary endpoint is assessed as time and type of death during the ICU-stay and 6 months after admission.
  
  
• Hospital Length of Stay [ Time Frame: open ] [ Designated as safety issue: No ]
  This secondary endpoint is assessed as days spent at the recruiting hospital from admission to discharge.
  
  
• Duration of Ventilation [ Time Frame: open ] [ Designated as safety issue: No ]
  This secondary endpoint is assessed as half-days on the ventilator until the patient is ventilator-independent for 24 h.
  
  
• Duration and Quality of Weaning [ Time Frame: Within ventilation time ] [ Designated as safety issue: No ]
  This secondary endpoint is assessed as half-days spent under the possible application of a weaning protocol, and spent within specific phases of such a protocol.
  
  
• Time of Analgosedation Dependence [ Time Frame: within ICU-LOS ] [ Designated as safety issue: No ]
  This secondary endpoint is assessed as half-days requiring the application of sedatives and analgesics which are also specified.
  
  
• Vasopressor Dependence [ Time Frame: within ICU-LOS ] [ Designated as safety issue: No ]
  This secondary endpoint is assessed as half-days spent under vasopressors.
  
  
• Time of Antibiotic Treatment [ Time Frame: within ICU-LOS ] [ Designated as safety issue: No ]
  This secondary endpoint is assessed as half-days under antibiotic treatment
  
  
• Pneumonias [ Time Frame: within ICU-LOS ] [ Designated as safety issue: Yes ]
  This secondary endpoint is assessed as episodes (pre-defined by diagnostic criteria) of pneumonia.
  
  
• Occurrence and Duration of Sepsis [ Time Frame: within ICU-LOS ] [ Designated as safety issue: Yes ]
  This secondary endpoint is assessed as the number of episodes and duration of sepsis as pre-defined by diagnostic criteria.
  
  
• Number and type of complications associated with the procedure [ Time Frame: 10 days post tracheostomy ] [ Designated as safety issue: Yes ]
  This secondary endpoint is assessed as the number and types of complications arelated to tracheostomy (i.e. bleeding, mispositioning, malfunction, replacement demand,etc.).
  
  
• Cost of Treatment [ Time Frame: within ICU-LOS ] [ Designated as safety issue: No ]
  This secondary endpoint is assessed as the total ICU-costs etsimated by length of stay and severety-derived DRG-multiplicator of each individual patient.
  
  

Background: Tracheostomy is a common procedure in critical care patients. Advantages of a short tracheal tube compared to a long orotracheal one are the avoidance of laryngeal lesions and sinusitis, facilitation of nursing care and physiotherapy and the reduction of analgosedatives. The optimal point in time for tracheostomy is still unknown, but it is commonly done not later than 2-3 weeks and after one or several failed extubation trials. Studies in different sets of critical care patients have suggested additional advantages of early tracheostomy: less pneumonias and other complications, more patient comfort, less analgosedation, shorter duration of ventilation and of ICU stay. These questions have not been looked at in non-traumatic neurocritical care patients, although these might have a special weaning benefit by early tracheostomy, being mainly compromised in securing their airway, but not in breathing.

Method: Non-traumatic Neurocritical care patients with ischemic strokes, intracerebral hemorrhage or subarachnoid hemorrhage so severly affected that 2 weeks of ventilation need are estimated, are principally eligible for the study. After randomization, one group receives tracheostomy within the first 3 days after intubation. The other group stays orotracheally intubated and is either weaned and extubated or receives tracheostomy within 7 to 14 days after intubation. Tracheostomy is done as percutaneous dilatation by neurologists.